CTRI/2021/09/036884Completed未知
To evaluate the Anti-dandruff efficacy of test regimen in healthy Indian human - None
nilever Industries Pvt Ltd0 sites205 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 205
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Female and male subjects in the ratio of 2:1 in general good health.
- •2.Subjects in the age group 18-42 years (both the ages inclusive).
- •3.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
- •4.Subjects willing to abide by and comply with the study protocol.
- •5.Subjects who have not participated in a similar investigation in the past three months.
- •6.Subjects who agree to refrain from using hair dye / hair colour /henna during the study period.
- •7.Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration
- •8.Subjects who agree not to change their regular regimen (including hair oils)
Exclusion Criteria
- •1.Subjects who have undergone hair growth treatment within 3 months before screening into the study.
- •2.Subjects having any active scalp disease which may interfere in the study ââ?¬â?? dermatologistââ?¬•s judgement.
- •3.Subjects (male) having androgenic alopecia, male pattern baldnessââ?¬• not be included in study.
- •4.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
- •5.Subjects (females) who are pregnant or lactating
- •6.Subjects who have had hair transplant.
- •7.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
- •8.Chronic illness which may influence the cutaneous state.
- •9.Subjects participating in other similar cosmetic or therapeutic trial within last three months
- •10.Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
- •11.Subjects (males) who are having androgenic alopecia, male pattern baldness.
Investigators
Similar Trials
Completed
Not Applicable
Hair Benefit Study For The Test ProductsCTRI/2021/09/036928nilever Industries Pvt Ltd207
Completed
Not Applicable
Evaluation of anti-dandruff Efficacy of Test products On Healthy Human SubjectsCTRI/2017/05/008658ITC LIMITED ITC Life Sciences and Technology Centre47
Not yet recruiting
Phase 2
Effect of the test product on dandruff controlCTRI/2023/09/057704Hindustan Unilever Limited
Completed
Not Applicable
Hair Benefit Study For The Test ProductsCTRI/2023/02/049737nilever Industries Pvt Ltd346
Not yet recruiting
Unknown
Anti-Dandruff Shampoo - EFFICACYCTRI/2023/03/050848GODREJ INDUSTRIES LTD.